Heparin-derived Sepsis Treatment
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
10
NCT05208112
Intravenously Administered M6229 in Critically Ill Sepsis Patients
Phase: Phase 1
Role: Collaborator
Start: Apr 5, 2022
Completion: Sep 28, 2023
Loading map...